{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"We Built It Because We Had To - Tech Founder Backstories","title":"His Data Found Carbon Monoxide Poisoning That Two Top Hospitals Missed (John Kelley)","html":"","width":"100%","height":180,"duration":2463,"description":"A teenager was diagnosed as paranoid schizophrenic by Cedars-Sinai, then again by Mayo Clinic. His furnace was poisoning him. It took John Kelley's data about 20 minutes to find it.\nIn this episode, Jonathan W. Buckley sits down with John Kelley, Chairman of CereHealth Corp and the iLLUME Ai platform - and, twenty years ago, the CEO and Chairman of McData Corp when Jonathan worked in its marketing organization. John explains why a Vietnam-era draftee watching friends come home with Agent Orange exposure, PTSD, and misdiagnoses decided in 2009 that the same data informatics Google and Amazon used to predict purchases could predict what was actually wrong inside a person's brain. He walks through the \"patients like me\" cohort model built on roughly 4,800 referred patients, why traumatic brain injury became the company's specialty, and how carbon monoxide binds to the iron in the basal ganglia and starves it of dopamine - the mechanism two of America's best hospitals missed.\nThe harder story is the go-to-market one. Pharma, insurance, and health systems - the three constituencies John assumed would embrace better diagnostics - all resisted, for rational reasons he lays out plainly. The VA, which should have been the natural ally, never engaged. Osteopathic physicians became the earliest adopters over MDs because they were trained to look at the whole system rather than the symptom. The company cleared the FDA in 120 days under the 21st Century Cures Act, immediately in Theranos's wake, got in front of four national carriers and Medicare, and then COVID arrived in March 2020 and took the momentum with it. Today the business has pivoted away from clinical services entirely, licensing its analytics engine as $2-4M enterprise contracts.\nJohn closes with the part most guests won't say out loud: after seven acquisitions across ten boards, he's not sure he was the right investor for this one - because he underestimated the resistance, and that's a due-diligence lesson, not...","thumbnail_url":"https://img.transistorcdn.com/qSYc3cBdFcsAT9NoNJB-b1WOXf_eKr0fZMdzan3rr64/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xNDI0/Y2Y5ZGEyNjlhMWQ4/OGRiNDdjNTc5YjQ3/YTQzOS5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}